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1. Introduction 
Profilin is a small basic protein (mol. wt 16 000) 
recently isolated in a 1: 1 complex with actin from 
calf spleen. This complex, called profilactin, is resis- 
tant to polymerisation; moreover, profilin will bind 
to depolymerised rabbit skeletal muscle actin to form 
a polymerisation-resistant complex [l]. There is evi- 
dence for the existence of a profilin:actin complex in 
a variety of cell types, including human platelets [ 11. 
Profilin may thus have an important regulatory influ- 
ence on the state of actin polymerisation in non-muscle 
cells [1,2]. 
Ultrastructural evidence suggests that the stimula- 
tion of platelets during blood clotting involves exten- 
sive filament formation from initially unpolymerised 
actin [3--S]. We show here that human platelets indeed 
contain profilin, which closely resembles the corre- 
sponding protein from calf spleen. There is sufficient 
profilin in extracts of fresh platelets to inhibit the 
polymerisation of at least 55% total actin. An as yet 
hypothetical general scheme for the formation of 
actin filaments from profilactin was presented [ 11. 
2. Materials and methods 
Assay of DNAase I was as in [6] and SDS-poly- 
acrylamide gel electrophoresis as in [7]. Viscosity was 
measured in a Cannon-Manning semi-micro capillary 
viscometer, requiring sample vol. 0.7 ml and having a 
flow time for buffer of about 60 s at 25’C. 
The concentrations of purified proteins were deter- 
mined from Asse, using extinction coefficients (E:%~) 
of 11 for actin and 13 for profilin [l]. 
3. Results and discussion 
Profiin was isolated from platelets obtained from 
platelet concentrate in plasma, supplied by Akademiska 
Sjukhuset, Uppsala. Platelets were washed 3 times at 
room temperature with phosphate-buffered saline 
pH 6.6, and the lower portion of the pellet, containing 
red and white blood cells, was discarded each time. 
Cells were then resuspended in 1 vol. 5 mM K2HP04, 
pH 7.6,0.1 mM CaCls, 0.5 mM ATP, 0.2 mM dithioery- 
thritol (DTE) and sonicated on ice for 4 X 5 s. All 
subsequent operations were carried out at 0-4’C. 
The extract was centrifuged for 3.5 h at 100 000 X g 
and the supernatant was applied to a Sephadex G-100 
column and eluted with 0.5 M KJ-IPOa, pH 7.6,0.2 mM 
DTE (fig.1). Actin elutes both as an aggregate in the 
void volume of the column and as a peak identified 
by assay of DNAase I inhibition (see fig.1). This peak 
appears in the position expected for profilactin [ 1,7]. 
Coincident with the peak of unpolymerised actin, but 
absent from the void volume, is a protein which 
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Fig.1. Chromatography of platelet extract on Sephadex 
G-100. About 12 ml packed platelets were sonicated in total 
vol. 35 ml buffer as described in the text. After centrifugation 
at 100 000 X g for 3.5 h, the supernatant, containing about 
530&z, units protein, was applied to a Sephadex G-100 
column (5 X 115 cm) and eluted with 0.5 M K,HPO,, pH 7.6, 
0.2 mM DTE at a flow rate of about 1 ml/min. Fractions 
(14 ml) were assayed for A,,, (0-o) and for DNAase 
I inhibitor activity (o--o). The lower part of the figure 
shows SDS-gel analysis of the fractions marked (v). The 
sample at the extreme right is the pooled material (fractions 
74-92). The positions of actin (A) and profilin (P) from 
spleen profilactin are marked. 
migrates close to calf spleen profilin on SDS gels. 
The association of the 16 000 dalton protein with 
unpolymerised actin in 0.5 M K2HP0.+ (fig.l), its unre- 
tarded passage through DEAE-cellulose in 2 M urea, 
and its molecular weight together suggest hat the 
protein isolated from platelets is protilin. This is con- 
firmed by the experiment shown in fig.3. Different 
amounts of either the platelet protein or calf spleen 
profilin, the latter prepared from profilactin by the 
DEAE-cellulose-urea method [ 11, were mixed with 
a fixed amount of depolymerised rabbit skeletal 
muscleactinin5mMKzHP04,pH7.6,0.1 mMCaCl*, 
0.1 mM ATP, 0.1 mM DTE. After incubation at 25°C 
for 10 min, NaCl and MgClz were added to final cone 
10 mM and 5 mM, respectively, and the actin polym- 
erisation was followed by viscometry. The prepara- 
tions from platelets and calf spleen cause equivalent 
inhibition of actin polymerisation. Further support 
for the identification ofhuman platelet profilin comes 
from close similarity between the amino acid compo- 
sitions of this protein and profilin from calf spleen 
(table 1) and from calf thymus and brain (unpublished 
observations). 
Fractions containing DNAase I inhibitor activity The following experiment places the profilin con- 
were pooled and concentrated by precipitation with tent of platelets in perspective with respect to the 
(NH&SO4 at 80% saturation. The precipitated mate- actin content. Actin inhibits DNAase 1 by formation 
rial was redissolved in and dialysed thoroughly against of a 1: 1 complex [8], and this interaction is much 
25 mM Tris-HCl, pH 7.6,5 mM MgClz, 0.2 mM DTE, more rapid with monomeric than with filamentous 
2 M urea, then passed through a DEAE-cellulose actin (unpublished observations; also [9]). Treatment 
column (DE52) in the same buffer. These are condi- with guanidine hydrochloride depolymerises fila- 
tions developed for the isolation of calf spleen profilin mentous actin but does not interfere with the actin- 
from profilactin [ 11: profilin can be recovered from DNAase I interaction. We have recently developed a 
the flow-through fraction while actin is retained on selective assay for monomeric and filamentous actin 
the column. For the experiments described here, the based on inhibition of DNAase I and utilising these 
material applied to the column is illustrated as the 
‘pool’ in fig.1, while the unretarded fraction, which is 
enriched in the 16 000 dalton component, is shown 
as the ‘start’ material in fig.2. 
The fraction not retained on DEAE-cellulose was 
precipitated with (NH&SO4 at 85% saturation, redis- 
solved in 5 mM K2HP04 pH 7.6,0.5 mM DTE, applied 
to a Sephadex G-75 column and eluted with the same 
buffer (tig.2). Azso located 2 peaks; the first eluted 
close to the void volume and was discarded. The 
second peak contained only the 16 000 dalton protein, 
as shown by gel electrophoresis of the pooled fractions. 
The pool was concentrated on a rotary evaporator to 
about 0.3 mg protein/ml, to facilitate subsequent 
precipitation with (NH&SO4 at 85% saturation. 
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Fig.Z.Chromatography ofpartly purified-platelet profiin on Sephadex G-75. Material not retained on DEAE-cellulose in 2 M urea 
(see text) was chromatographed on Sephadex G-75 in 5 mM K,HPO,, pH 7.6,0.5 mM DTE. About 3.7 A,,, units protein in 1 ml 
was applied to a 1.5 X 120 cm column and eluted at 0.25 ml/min. SDS-gel analysis of the starting material, the pool (marked by 
( &--j) on the chromatogram) and spleen profilactin (PA) are shown in the inset. 
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Fig.3. Recombination of profilin with muscle actin. Depolymerised rabbit skeletal muscle actin (0.29 mg) was mixed with buffer 
(A) or with either platelet or calf spleen profiin in stoichiometric ratio to profilin 1:0.46 (0) and 1:0.92 (0). After incubation for 
10 min at 25”C, NaCl and MgCl, were added to 10 mM and 5 mM, respectively, and actin polymerisation was followed by vis- 
come try. 
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Table 1 
Amino acid composition of profilin from calf spleen and 
human platelets 
Calf spleen Human platelets 
Aspartic acid 
Threonine 
Serine 
Glu tamic acid 
Proline 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Lysine 
Histidine 
Arginine 
15 15-16 
12-13 12 
10-11 12 
12 10 
6- 7 5 
20 17-18 
13 11 
12 12 
6 4- 5 
7 6 
12 15-16 
4 4 
5 3- 4 
10 10 
2 2 
4- 5 5 
- 
100 000 X g removed polymerised actin, while leaving 
more than 90% of the DNAaseI-inhibitor activity in 
the supernatant. After chromatography of the super- 
natant on Sephadex G-100 in 5 mM KzHP04, pH 7.6, 
150mMNaCl,0.1m~CaC12,0.2mMDTE,80%ofthe 
applied DNAase I inhibitor activity was recovered in 
the peak eluting in the position of prolilactin. Elec- 
trophoretic analysis of the fractions in this peak and 
densitometry of the stained gels showed that the aver- 
age actin: profilin ratio was 0.94: 1 (range 0.81-l .12: 1). 
Thus at least 75% of the polymerisation-resistant actin 
in the original extract is profilactin. No profilin eluted 
from the Sephadex column in the position expected 
for the free protein. 
Analyses were performed on samples hydrolysed for 24 h, 
48 h and 72 h, using a Durham amino acid analyser. Integral 
numbers for the amino acid residues are calculated from 15 600 
for the molecular weight of profilin. Cysteine and tryptophan 
were not determined 
properties: the details of the assay will be published 
elsewhere (in preparation). Application of this method 
to extracts of platelets made under polymerising con- 
ditions indicate that 45-70% total actin is unpolym- 
erised, even at total actin cont. - 5 mg/ml: in general, 
older batches of platelets contain a lower proportion 
of unpolymerised actin. From batches of cells which 
gave 60% and 70% unpolymerised actin, extracts were 
made in conditions where actin depolymerises (5 mM 
K2HP04,pH7.6,0.1 mMCaC12,0.1 mMATP,0.2mM 
DTE); subsequent addition of 150 mM NaCl and 2 mM 
MgClz resulted in the polymerisation of no more than 
40% and 30% actin, respectively. This supports the 
conclusion that the remaining fraction is polymerisa- 
tion-resistant. 
A fraction of platelet actin with unusual polymerisa- 
tion properties has been reported by other workers. 
Nearly half the platelet actin isolated under depolym- 
erlsing conditions was resistant to polymerisation [lo]. 
The existence of profilin in platelets can provide an 
explanation for this observation. In isolating actin 
from a crude platelet actomyosin preparation [ 111, it 
was observed that about 30% of the material was 
included in a Sepharose 4B column in 0.5 M KCl. 
This fraction is of interest because it contained primar- 
ily 2 polypeptides ofmol. wt 45 000 and 16 000 [ 111. 
The relationship between these results and our obser- 
vations is not yet established. 
Platelets are of particular interest in cell motility 
studies because of their cytological simplicity and the 
dramatic changes in morphology and ultrastructure 
resulting from stimulation [3-51. In view of the high 
proportion ofactin combined with profilin in extracts 
of these cells, we regard the stimulation of platelets as 
one of the most promisingmodel systems for studying 
the role of profilactin in cell motility. 
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